What SURMOUNT showed about Zepbound's active molecule The weight-management evidence for tirzepatide comes chiefly from the SURMOUNT program, published in The New England Journal of Medicine in 2022, with SURMOUNT-OSA (NEJM 2024) studying obstructive sleep apnea
Experience sustained energy and mental clarity without the crash
Receive monthly shipments
If you want a deeper look at how this medication fits into treatment, our guide on how to get tirzepatide for weight loss is a useful next step
A recent clinical study found that omega-3 supplementation and Read More Key Takeaways GLP-1 drugs restrict calorie intake, leading to rapid metabolic benefits
A lower, fixed dose for those who want a gentle, mindful, cosmetic approach rather than full dose weight loss